Psoriasis Screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There is no consensus on screening for psoriasis among the general population but screening methods exist, which can be used | There is no consensus on screening for psoriasis among the general population but screening methods exist, which can be used to screen for psoriasis. These screening methods include the psoriasis screening tool (PST) and [[genetic testing]]. | ||
==Screening== | ==Screening== | ||
| Line 14: | Line 14: | ||
*A sample for [[genetic testing]] is usually taken from a cheek swab. | *A sample for [[genetic testing]] is usually taken from a cheek swab. | ||
===Psoriasis screening tool (PST)=== | ===Psoriasis screening tool (PST)=== | ||
*The Psoriasis Screening Tool (PST) consists of eight close ended questions with a "yes" or "no" response with typical images of [[skin]], [[Nail (anatomy)|nail]] and [[scalp]] changes in psoriasis included with respective questions.<ref name="pmid19566664">{{cite journal |vauthors=Dominguez PL, Assarpour A, Kuo H, Holt EW, Tyler S, Qureshi AA |title=Development and pilot-testing of a psoriasis screening tool |journal=Br. J. Dermatol. |volume=161 |issue=4 |pages=778–84 |year=2009 |pmid=19566664 |doi=10.1111/j.1365-2133.2009.09247.x |url=}}</ref> | *The Psoriasis Screening Tool (PST) consists of eight close ended questions with a "yes" or "no" response with typical images of [[skin]], [[Nail (anatomy)|nail]], and [[scalp]] changes in psoriasis included with respective questions.<ref name="pmid19566664">{{cite journal |vauthors=Dominguez PL, Assarpour A, Kuo H, Holt EW, Tyler S, Qureshi AA |title=Development and pilot-testing of a psoriasis screening tool |journal=Br. J. Dermatol. |volume=161 |issue=4 |pages=778–84 |year=2009 |pmid=19566664 |doi=10.1111/j.1365-2133.2009.09247.x |url=}}</ref> | ||
*The questions distinguish individuals with psoriasis from individuals without the disease in an [[Outpatient|outpatient setting]]. | *The questions distinguish individuals with psoriasis from individuals without the disease in an [[Outpatient|outpatient setting]]. | ||
*A similar questionnaire exists for [[psoriatic arthritis]], called the Psoriasis Epidemiology Screening Tool (PEST).<ref name="urlPsoriasis Epidemiology Screening Tool (PEST): A Report from the GRAPPA 2009 Annual Meeting | The Journal of Rheumatology">{{cite web |url=http://www.jrheum.org/content/38/3/551.long |title=Psoriasis Epidemiology Screening Tool (PEST): A Report from the GRAPPA 2009 Annual Meeting | The Journal of Rheumatology |format= |work= |accessdate=}}</ref> | *A similar questionnaire exists for [[psoriatic arthritis]], called the Psoriasis Epidemiology Screening Tool (PEST).<ref name="urlPsoriasis Epidemiology Screening Tool (PEST): A Report from the GRAPPA 2009 Annual Meeting | The Journal of Rheumatology">{{cite web |url=http://www.jrheum.org/content/38/3/551.long |title=Psoriasis Epidemiology Screening Tool (PEST): A Report from the GRAPPA 2009 Annual Meeting | The Journal of Rheumatology |format= |work= |accessdate=}}</ref> | ||
Revision as of 15:34, 3 August 2017
|
Psoriasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Psoriasis Screening On the Web |
|
American Roentgen Ray Society Images of Psoriasis Screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
There is no consensus on screening for psoriasis among the general population but screening methods exist, which can be used to screen for psoriasis. These screening methods include the psoriasis screening tool (PST) and genetic testing.
Screening
Genetic screening for psoriasis
- The strong association of psoriasis with genetics allows screening for this disease via genetic testing.
- HLA Class I antigens (HLA-B13, HLA-B57, HLA-B39, HLA-Cw6, HLACw7) have been known to be associated with psoriasis and psoriatic arthritis.[1]
- HLA-B13, -B16, and its splits -B38 and -B39, B17, and Cw6 are associated with psoriasis, with or without arthritis.
- Early screening combined with early treatment can help prevent disease progression.
- A sample for genetic testing is usually taken from a cheek swab.
Psoriasis screening tool (PST)
- The Psoriasis Screening Tool (PST) consists of eight close ended questions with a "yes" or "no" response with typical images of skin, nail, and scalp changes in psoriasis included with respective questions.[2]
- The questions distinguish individuals with psoriasis from individuals without the disease in an outpatient setting.
- A similar questionnaire exists for psoriatic arthritis, called the Psoriasis Epidemiology Screening Tool (PEST).[3]
References
- ↑ Gladman DD, Farewell VT (2003). "HLA studies in psoriatic arthritis: current situation and future needs". J. Rheumatol. 30 (1): 4–6. PMID 12508382.
- ↑ Dominguez PL, Assarpour A, Kuo H, Holt EW, Tyler S, Qureshi AA (2009). "Development and pilot-testing of a psoriasis screening tool". Br. J. Dermatol. 161 (4): 778–84. doi:10.1111/j.1365-2133.2009.09247.x. PMID 19566664.
- ↑ "Psoriasis Epidemiology Screening Tool (PEST): A Report from the GRAPPA 2009 Annual Meeting | The Journal of Rheumatology".